Biggest News Aggregation in the World
๐Ÿ“ฐ Cherilyn Cecchini News

Cherilyn Cecchini News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cherilyn Cecchini. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Amolyt Pharma to Host Hybrid Key Opinion Leader Event on its Potential Hypoparathyroidism Treatment, AZP-3601, on Monday, September 12th at 1:30pm CT/2:30pm ET in Austin, Texas

KOL event to follow company's presentation at the American Society for Bone and Mineral Research (ASBMR) 2022 Annual MeetingLYON, France and CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Amolyt
United Kingdom United States Kostenloser Wertpapierhandel Mark Sumeray Ashley Robinson Amolyt Pharma

Investegate |Amolyt Pharma Announcements | Amolyt Pharma: Amolyt Pharma to Host Hybrid Key Opinion Leader Event on its Potential Hypoparathyroidism Treatment, AZP-3601, on Monday, September 12th at 1:30pm CT/2:30pm ET in Austin, Texas

Investegate announcements from Amolyt Pharma, Amolyt Pharma to Host Hybrid Key Opinion Leader Event on its Potential Hypoparathyroidism Treatment, AZP-3601, on Monday, September 12th at 1:30pm CT/2:30pm ET in Austin, Texas
United Kingdom United States Mark Sumeray Ashley Robinson Amolyt Pharma Deb Murphy

Amolyt Pharma Announces Two Presentations, Including Phase 2a Data for AZP-3601 in Patients with Hypoparathyroidism, at the American Society for Bone and Mineral Research 2022 Annual Meeting

Company to host Key Opinion Leader webinar on September 12 at 2:00 pm CT/3:00 pm ETLYON, France and CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing
United Kingdom United States Kostenloser Wertpapierhandel Twitterand Linkedin Ashley Robinson Amolyt Pharma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science